Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B

被引:163
作者
Li, L
El-Kholy, W
Rhodes, CJ
Brubaker, PL
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
[2] Pacific NW Res Inst, Seattle, WA USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
关键词
Akt; apoptosis; beta cell; cytokines; exendin-4; glucagon-like peptide-1; inducible nitric oxide synthase; necrosis; protein kinase B; reactive oxygen species;
D O I
10.1007/s00125-005-1787-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis: The gut hormone glucagon-like peptide-1 (GLP-1) decreases beta cell apoptosis in a protein kinase B (PKB)-dependent fashion, and increases islet cell mass and function in vivo. In contrast, cytokines induce beta cell apoptosis, leading to decreased islet mass and type 1 diabetes. In the present study we used rat INS-1E beta cells and primary rat islet cells to examine the potential role of PKB as a mediator of the effect of GLP-1 on cytokine-induced apoptosis. Methods: Cell viability was determined by MTTassay, and apoptosis and necrosis by Hoechst 33342-propidium iodide staining. Immunoblot analysis was used to detect changes in protein expression, including active (phosphorylated) and total PKB, phosphorylated and total glycogen synthase kinase-3 beta, activated caspase-3 and inducible nitric oxide synthase. Reactive oxygen species were determined by 1,7-dichlorofluorescein (DCF) analysis, and mutant forms of PKB were introduced into cells using adenoviral vectors. Results: Incubation of INS-1E cells with cytokines (IL-1 beta, TNF-alpha and interferon-gamma; 10-50 ng/ml) for 18 h significantly decreased cell viability ( by 44%, p < 0.001), cell proliferation ( by 80%, p < 0.001), and activation of PKB (by 67%, p < 0.001). Pre-treatment with exendin-4 (10(-7) mol/l), a long-acting GLP-1 receptor agonist, partially protected the cells against cytokine-induced toxicity (p < 0.01) in association with a reduction in cytokine-induced inhibition of PKB phosphorylation (p < 0.05). Exendin-4 pre-treatment did not change cell proliferation. Cytokine treatment increased apoptosis (by 156%, p < 0.05) and necrosis (from undetectable to 2.6% of cells). These increases were both reduced by pre-treatment with exendin-4 (p < 0.05-0.01). Furthermore, cytokine-induced apoptosis and necrosis were significantly increased in cells infected with kinase-dead PKB (p < 0.05), and the protective effect of exendin-4 on both parameters was fully abolished in these cells. Similar changes were observed in primary islet cells. In parallel with these changes, exendin-4 decreased the cytokine-induced activation of caspase-3 (by 46%, p < 0.05), and decreased levels of inducible nitric oxide synthase ( by 71%, p < 0.05) and reactive oxygen species (by 27%, p < 0.05). Conclusions/interpretation: The results of our study indicate that GLP-1 plays a protective role against cytokine-induced apoptosis and necrosis in beta cells through a PKB-dependent signalling pathway.
引用
收藏
页码:1339 / 1349
页数:11
相关论文
共 55 条
  • [1] Phosphatidylinositol 3-kinase signaling to Akt mediates survival in isolated canine islets of Langerhans
    Aikin, R
    Rosenberg, L
    Maysinger, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (02) : 455 - 461
  • [2] ESTABLISHMENT OF 2-MERCAPTOETHANOL-DEPENDENT DIFFERENTIATED INSULIN-SECRETING CELL-LINES
    ASFARI, M
    JANJIC, D
    MEDA, P
    LI, GD
    HALBAN, PA
    WOLLHEIM, CB
    [J]. ENDOCRINOLOGY, 1992, 130 (01) : 167 - 178
  • [3] Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia
    Bernal-Mizrachi, E
    Wen, W
    Stahlhut, S
    Welling, CM
    Permutt, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (11) : 1631 - 1638
  • [4] Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
    Brubaker, PL
    Drucker, DJ
    [J]. ENDOCRINOLOGY, 2004, 145 (06) : 2653 - 2659
  • [5] Brubaker PL, 2003, CAN J PHYSIOL PHARM, V81, P1005, DOI [10.1139/y03-107, 10.1139/Y03-107]
  • [6] Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis -: Involvement of phosphatidylinositol 3-kinase
    Castrillo, A
    Bodelón, OG
    Boscá, L
    [J]. DIABETES, 2000, 49 (02) : 209 - 217
  • [7] Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells
    Delaney, CA
    Pavlovic, D
    Hoorens, A
    Pipeleers, DG
    Eizirik, DL
    [J]. ENDOCRINOLOGY, 1997, 138 (06) : 2610 - 2614
  • [8] Pancreatic β-cell growth and survival in the onset of type 2 diabetes:: a role for protein kinase B in the Akt?
    Dickson, LM
    Rhodes, CJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 287 (02): : E192 - E198
  • [9] Differential activation of protein kinase B and p70S6K by glucose and insulin-like growth factor 1 in pancreatic β-cells (INS-1)
    Dickson, LM
    Lingohr, MK
    McCuaig, J
    Hügl, SR
    Snow, L
    Kahn, BB
    Myers, MG
    Rhodes, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 21110 - 21120
  • [10] Inflammatory mediators and islet β-cell failure:: a link between type 1 and type 2 diabetes
    Donath, MY
    Storling, J
    Maedler, K
    Mandrup-Poulsen, T
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (08): : 455 - 470